NovaNutrition
NovaNutrition manufactures and distributes the Novalac brand of evidence-based specialty infant and toddler formulas for conditions including cow's milk protein allergy, reflux, colic, constipation, and excessive hunger, sold exclusively through pharmacy retail channels across Australia and 50+ countries.
- Company typePrivate
- Founded1991
- HeadquartersNewcastle, Australia
- Headcount—
- GTM typeB2C
- OfferingHardware or Manufacturing
NovaNutrition firmographics
Firmographics- Name
- NovaNutrition
- Legal name
- Aspen Pharmacare Australia Pty Ltd
- Website
- https://novanutrition.com.au
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Short description
- NovaNutrition manufactures and distributes the Novalac brand of evidence-based specialty infant and toddler formulas for conditions including cow's milk protein allergy, reflux, colic, constipation, and excessive hunger, sold exclusively through pharmacy retail channels across Australia and 50+ countries.
- Ownership category
- akta.pro rank
NovaNutrition industry classification
Industry- Product category
- Specialty Infant Formula
- NAICS
- Dairy Product Manufacturing (3115), Dairy Product (except Frozen) Manufacturing (31151)
- SIC
- Dairy Products (2020)
- akta.pro primary industry
- Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic) (CRADAEAB)
- akta.pro secondary industries
- Special Medical Purpose Infant Formula Manufacturing (FSMP/Medical Nutrition) (AFAHAHAC), Toddler & Pediatric Nutritional Powder Manufacturing (Milk-Based) (AFAHAHAH)
Keywords
Where NovaNutrition is headquartered
LocationHeadquarters
- HQ city
- Newcastle
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
NovaNutrition business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Marketing or Sales, Personnel
Revenue model
- Specialty Infant Formula Sales: NovaNutrition generates revenue through the sale of specialty infant and toddler formulas designed to manage common feeding conditions including reflux, colic, constipation, cow's milk protein allergy, and excessive hunger. Products are sold exclusively through pharmacy retail channels.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Novalac specialty infant formulas are sold at retail pharmacy pricing set by individual retailers |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels4 records
NovaNutrition product offering
Product offeringCore offering
NovaNutrition manufactures and distributes the Novalac range of premium, evidence-based specialty infant and toddler formulas designed to provide nutrition while managing common feeding conditions. The six-product range addresses cow's milk protein allergy, lactose intolerance, reflux, colic, constipation, and excessive hunger in formula-fed infants and toddlers. Products are sold exclusively through pharmacy retail channels in Australia and across 50+ countries worldwide, with formulations backed by 25+ years of clinical research involving 48,000+ infants.
Product overview
NovaNutrition offers Novalac, a premium evidence-based specialty infant and toddler formula brand designed to provide complete nutrition while helping to manage common feeding conditions. The product portfolio consists of six specialty formulas: Novalac Allergy and Novalac Allergy Toddler (for cow's milk protein allergy and lactose intolerance, using rice protein), Novalac Reflux (for reflux symptoms), Novalac Colic (for colic and digestive discomfort), Novalac Constipation (for constipation relief), and Novalac Sweet Dreams (for excessively hungry babies). All products are suitable for ongoing everyday use and are available in pharmacies across Australia. The company emphasizes clinical research backing (50+ clinical trials, 48,000+ infants), European manufacturing standards, and 700+ quality controls throughout production.
Differentiator
Problem solved
Functional benefit
Products and services
- Novalac Allergy
Quantifiable outcome
- 50+ clinical trials involving more than 48,000 infants globally demonstrate formula effectiveness
- +2 more outcomes
Companies that use NovaNutrition
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
NovaNutrition technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
NovaNutrition partnerships and signals
Strategic signalScale indicators8 records
Recent moves5 records
Expansion highlights5 records
NovaNutrition competitors and assessment
Company assessmentRegional players
- Bubs Australia: Bubs Australia is an Australian goat's milk infant formula brand distributed through pharmacy and grocery channels, competing directly with Novalac for the same Australian specialty-formula consumer.
- Bellamy's Organic: Bellamy's Organic is an Australian-based infant and toddler formula brand with overlapping pharmacy distribution and a similar positioning around premium, science-backed nutrition for Australian parents.
- Hero Group: Hero Group (Hero Baby) is a European-headquartered infant nutrition manufacturer with specialty and standard formulas sold across European pharmacy and grocery channels, comparable to Novalac's European-manufactured, condition-targeted positioning.
- a2 Milk Company: a2 Milk Company is an Australian-listed dairy nutrition business with an infant formula range (a2 Platinum) distributed through pharmacies and grocery, competing in the same Australian specialty infant nutrition category.
- HiPP: HiPP is a European family-owned infant nutrition specialist with a strong specialty and organic formula range sold through European pharmacies, comparable to Novalac in clinical-evidence positioning and pharmacy-channel distribution.
Direct peers
- Danone (Nutricia / Aptamil / Karicare): Danone's Nutricia early-life nutrition division (Aptamil, Karicare) is the closest global comparable to Novalac, selling specialty and standard infant formulas through pharmacy and grocery channels with similar clinical-evidence positioning and condition-specific product extensions.
- Reckitt Benckiser (Mead Johnson / Enfamil): Mead Johnson's Enfamil line (owned by Reckitt) is a global specialty infant formula competitor with comparable condition-targeted SKUs (e.g., Nutramigen for cow's milk allergy) and a similar pharmacy/healthcare-professional-driven distribution model.
Broad incumbents
- Aspen Pharmacare: Aspen Pharmacare is the diversified pharmaceutical parent that owns and licenses the Novalac brand in Australia; its broader portfolio (pharma, consumer health) sets the strategic and capital-allocation context within which Novalac operates.
- Abbott Laboratories: Abbott's Similac line competes directly in the specialty infant formula category (e.g., Similac Alimentum for cow's milk allergy), with similar pharmacy and hospital channel presence and clinical-evidence-led positioning.
- Nestlé: Nestlé (NAN, Gerber) is the global volume leader in infant nutrition and operates across standard and specialty formulas, providing the scale benchmark and primary competitive pressure for any specialty infant formula brand.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
NovaNutrition social profiles
Digital presenceNovaNutrition financial estimates
Financial estimateRevenue estimate
Valuation estimate
NovaNutrition leadership team
Management profileNumber of profiles
NovaNutrition funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NovaNutrition M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NovaNutrition
What does NovaNutrition do?
NovaNutrition manufactures and distributes the Novalac range of premium, evidence-based specialty infant and toddler formulas designed to provide nutrition while managing common feeding conditions. The six-product range addresses cow's milk protein allergy, lactose intolerance, reflux, colic, constipation, and excessive hunger in formula-fed infants and toddlers. Products are sold exclusively through pharmacy retail channels in Australia and across 50+ countries worldwide, with formulations backed by 25+ years of clinical research involving 48,000+ infants.
Is NovaNutrition a public or private company?
NovaNutrition is a private company. It is classified as corporate owned and is currently operating.
When was NovaNutrition founded?
NovaNutrition was founded in 1991.
Where is NovaNutrition based?
NovaNutrition is headquartered in Newcastle, Australia, in the Oceania region.
How does NovaNutrition make money?
One revenue line is on record: specialty Infant Formula Sales.
Who are NovaNutrition's main competitors?
Regional players on record are Bubs Australia, Bellamy's Organic, Hero Group, a2 Milk Company and HiPP. Direct peers are Danone (Nutricia / Aptamil / Karicare) and Reckitt Benckiser (Mead Johnson / Enfamil). Broad incumbents are Aspen Pharmacare, Abbott Laboratories and Nestlé.
Does NovaNutrition have an API?
No public API is recorded for NovaNutrition.
What industry is NovaNutrition in?
NovaNutrition's product category is Specialty Infant Formula. Its primary akta.pro industry code is CRADAEAB, Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic), with a secondary code of AFAHAHAC, Special Medical Purpose Infant Formula Manufacturing (FSMP/Medical Nutrition). Its NAICS code is 3115 and its SIC code is 2020.